Home › NDC Lookup › RxCUI directory › RxCUI 1291672

Lidocaine 0.04 MG/MG Topical Gel — RxCUI 1291672

RxNorm drug concept · Semantic clinical drug
RxCUI 1291672 Semantic clinical drug · SCD ● Current RxNorm concept 10 FDA products 13 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1291672
Official nameLidocaine 0.04 MG/MG Topical Gel
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslidocaine 4 % Topical Gel
FDA products mapped10
Package NDCs mapped13
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Lidocaine Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • This patch is used to treat post-herpetic neuralgia — that's the persistent burning or aching nerve pain that sometimes sticks around after a shingles outbreak, even after the rash...
  • What is this patch actually for — why did my doctor prescribe it?
  • You wear it for up to 12 hours, then take it off for the next 12 hours — think of it as '12 hours on, 12 hours off.' Your prescriber may allow up to 3 patches at a time, but never...
  • How long do I wear the patch, and can I wear more than one?
📖 Read our full Lidocaine Transdermal Patch guide →

🕸️ Concept Web — How Lidocaine 0.04 MG/MG Topical Gel Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Lidocaine 0.04 MG/MG Topical Gel RxCUI 1291672

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Lidocaine 6387
  2. Brand names 4

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Comfortcaine 1592286
    • Sonacaine 1291673
    • Topicaine 1650997
    • Zcaine 1292873
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Lidocaine Topical Gel 377965
    • Lidocaine Topical Product 1164666
    • Lidocaine Topical Gel [Comfortcaine] 1592288
    • Lidocaine Topical Gel [Sonacaine] 1291675
    • Lidocaine Topical Gel [Topicaine] 1650999
    • Lidocaine Topical Gel [Zcaine] 1292875
    • Comfortcaine Topical Product 1592289
    • Sonacaine Topical Product 1291676
    • +4 more in this family
  4. Clinical & branded drugs 9

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 21 of 26 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Lidocaine 0.04 MG/MG SCDC · 340128
  • Lidocaine Topical Gel SCDF · 377965
  • Lidocaine Topical Product SCDG · 1164666

Brand-Name Concepts

📦 FDA Products & Package NDCs

10 products · 13 package NDCs
13 package NDCs map to RxCUI 1291672 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
27789-0911-02 60 g in 1 BOTTLE (27789-911-02) Zcaine Fast Acting Anesthetic PHI, Inc 2012-04-04
49911-0884-01 28.35 g in 1 BOTTLE (49911-884-01) Plum Smooth Plumb Numb Gelee Universal Companies, Inc. 2012-03-29
49947-0002-02 56.7 g in 1 BOTTLE (49947-002-02) Hush Anesthetic HUSH Anesthetic 2023-05-11
49947-0002-04 113.4 g in 1 BOTTLE (49947-002-04) Hush Anesthetic HUSH Anesthetic 2023-05-11
62221-0935-02 60 g in 1 BOTTLE (62221-935-02) Sonacaine Topical Anesthetic With Menthol Filltech USA, LLC 2012-05-02
63135-0312-04 113 g in 1 TUBE (63135-312-04) TOPICAINE ESBA LABORATORIES INC. 2003-04-20
63135-0312-13 1 TUBE in 1 BOX (63135-312-13) / 10 g in 1 TUBE TOPICAINE ESBA LABORATORIES INC. 2003-04-20
63135-0312-30 1 TUBE in 1 BOX (63135-312-30) / 30 g in 1 TUBE TOPICAINE ESBA LABORATORIES INC. 2003-04-20
65008-0005-04 1 BOTTLE, PLASTIC in 1 CARTON (65008-005-04) / 113 g in 1 B... Comfortcaine QS Key West Aloe, LLC 2023-06-23
69747-0040-01 113 g in 1 TUBE (69747-040-01) Greencaine Blast ALMA Laboratories, Inc. 2018-01-18
70466-0001-01 1 TUBE in 1 PACKAGE (70466-001-01) / 28.3 g in 1 TUBE Bed Bug Instant Bite Relief P.F. Harris Mfg. Co. LLC 2016-02-04
71888-0102-02 12 PACKET in 1 BOX (71888-102-02) / 4 mL in 1 PACKET (71888... Lidocaine Bellus Medical, LLC 2017-06-01
82517-0002-04 118 mL in 1 BOTTLE (82517-002-04) Hunter Beach 4% HUNTERS BEACH LIFE 2022-01-01
Observed labelers: ESBA LABORATORIES INC. (3) · HUSH Anesthetic (2) · ALMA Laboratories, Inc. (1) · Bellus Medical, LLC (1) · Filltech USA, LLC (1) · HUNTERS BEACH LIFE (1) · +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.